Synopses & Reviews
Annual Reports in Medicinal Chemistry provides timely and critical reviews of important topics in medicinal chemistry together with an emphasis on emerging topics in the biological sciences, which are expected to provide the basis for entirely new future therapies.
Review
"This series is one of the very few annual publications which justify the title of an absolute must for the pharmacologist, chemist, or physician who is interested in the chemistry of drug development."
—ENZYMOLOGIA
"This book is strongly recommended for researchers, teachers, students, administrators—in short, anyone whose interests impinge on medicinal chemistry. In view of the work's documented reference value, it is a must for inclusion in the scientist's personal library."
—JOURNAL OF MEDICINAL CHEMISTRY
"All topics are covered in sufficient depth, with extensive references, to allow either the specialist or the novice to be informed of the latest developments in a particular area of medicinal chemistry."
—JOURNAL OF PHARMACEUTICAL SCIENCES
Review
"This series is one of the very few annual publications which justify the title of an absolute must for the pharmacologist, chemist, or physician who is interested in the chemistry of drug development."
ENZYMOLOGIA
"This book is strongly recommended for researchers, teachers, students, administrators in short, anyone whose interests impinge on medicinal chemistry. In view of the work's documented reference value, it is a must for inclusion in the scientist's personal library."
JOURNAL OF MEDICINAL CHEMISTRY
"All topics are covered in sufficient depth, with extensive references, to allow either the specialist or the novice to be informed of the latest developments in a particular area of medicinal chemistry."
JOURNAL OF PHARMACEUTICAL SCIENCES
Table of Contents
I. CENTRAL NERVOUS SYSTEM DISEASES
Section Editor: David W. Robertson, Pfizer Global ResearchandDevelopment, Ann Arbor, MI
II. CARDIOVASCULAR AND PULMONARY DISEASES
Section Editor: William J. Greenlee, Schering-Plough Research Institute,
Kenilworth, New Jersey
III. CANCER AND INFECTIOUS DISEASES
Section Editor: Jacob J. Plattner, Chiron Corporation, Emeryville, California
IV. IMMUNOLOGY, ENDOCRINOLOGY AND METABOLIC DISEASES
Section Editor: William K. Hagmann, Merck Research Laboratories,
Rahway, New Jersey
V. TOPICS IN BIOLOGY
Section Editor: Janet M. Allen, Inpharmatica, London, United Kingdom
VI. TOPICS IN DRUG DESIGN AND DISCOVERY
Section Editor: George L. Trainor, DuPont Pharmaceuticals Company,
Wilmington, Delaware
VII. TRENDS AND PERSPECTIVES
Section Editor: Annette M. Doherty, Pfizer Global ResearchandDevelopment,
Fresnes Laboratories, Fresnes, France